Neuroprotective and Disease-Modifying Effects of the Triazinetrione ACD856, a Positive Allosteric Modulator of Trk-Receptors for the Treatment of Cognitive Dysfunction in Alzheimer’s Disease

The introduction of anti-amyloid monoclonal antibodies against Alzheimer’s disease (AD) is of high importance. However, even though treated patients show very little amyloid pathology, there is only a modest effect on the rate of cognitive decline. Although this effect can possibly increase over tim...

Descripción completa

Detalles Bibliográficos
Autores principales: Parrado Fernandez, Cristina, Juric, Sanja, Backlund, Maria, Dahlström, Märta, Madjid, Nather, Lidell, Veronica, Rasti, Azita, Sandin, Johan, Nordvall, Gunnar, Forsell, Pontus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342804/
https://www.ncbi.nlm.nih.gov/pubmed/37446337
http://dx.doi.org/10.3390/ijms241311159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342804/
https://www.ncbi.nlm.nih.gov/pubmed/37446337
http://dx.doi.org/10.3390/ijms241311159

Ejemplares similares